experi
conduct
evalu
whether
pretreat
fenofibr
could
mitig
acut
lung
injuri
ali
mice
model
intestin
ischemiareperfus
ir
male
mice
randomli
assign
three
group
n
sham
intestin
ir
vehicl
intestin
ir
fenofibr
intestin
ir
achiev
clamp
superior
mesenter
arteri
fenofibr
mgkg
equal
volum
vehicl
inject
intraperiton
minut
ischemia
end
experi
measur
pathohistolog
score
inflammatori
mediat
marker
perform
addit
surviv
experi
conduct
intestin
ir
mice
treat
fenofibr
vehicl
chief
result
anticip
pathohistolog
evalu
indic
fenofibr
amelior
local
intestin
damag
distant
lung
injuri
pretreat
fenofibr
significantli
decreas
inflammatori
factor
intestin
lung
consist
renal
creatin
level
hepat
alt
level
significantli
decreas
fenofibr
group
moreov
serum
system
inflammatori
respons
indic
significantli
allevi
fenofibr
group
addit
fenofibr
administr
significantli
improv
surviv
rate
collect
data
indic
pretreat
fenofibr
prior
ischemia
attenu
intestin
ir
injuri
ali
acut
lung
injuri
ali
critic
sever
lifethreaten
condit
icu
character
high
mortal
approxim
ali
along
sever
form
acut
respiratori
distress
syndrom
often
result
massiv
insult
lung
whether
direct
alveolar
infiltr
indirect
effect
system
inflammatori
respons
syndrom
multipl
organ
dysfunct
syndrom
effect
treatment
lifethreaten
disord
call
better
understand
molecular
pathophysiolog
ali
intestin
recogn
one
largest
immun
barrier
system
sourc
bacteria
endotoxin
bodi
previou
report
indic
intestin
organ
play
crucial
role
develop
ali
mesenter
arteri
ischemia
commonli
seen
critic
state
small
bowel
transplant
trauma
may
lead
intestin
ischemiareperfus
ir
injuri
process
intestin
ir
injuri
local
bacteria
overgrow
transloc
gastrointestin
mobil
decreas
mucos
permeabl
increas
subsequ
lead
local
intestin
damag
distant
lung
injuri
activ
system
inflammatori
respons
syndrom
multipl
organ
dysfunct
syndrom
intestin
ir
therefor
use
model
investig
pathophysiolog
mechan
indirect
ali
fenofibr
known
agonist
peroxisom
proliferatoractiv
receptor
nuclear
receptor
superfamili
member
nuclear
receptor
activ
fenofibr
upregul
downregul
gene
involv
mani
pathophysiolog
process
oxid
stress
inflamm
leukocyt
endothelium
interact
recent
studi
demonstr
antioxid
antiinflammatori
antiischem
role
fenofibr
attenu
ir
injuri
kidney
liver
brain
heart
date
literatur
report
protect
effect
fenofibr
ir
injuri
organ
intestin
moreov
function
signific
fenofibr
intestin
irinduc
ali
remain
unclear
therefor
experi
aim
investig
whether
fenofibr
administr
would
amelior
lung
injuri
inflamm
model
intestin
ir
injuri
anim
male
mice
g
purchas
charl
river
beij
china
mice
kept
temperatur
humid
control
room
lightdark
cycl
fed
standard
mice
chow
water
ad
liblitum
experi
perform
accord
declar
helsinki
approv
institut
anim
ethic
committe
peke
union
medic
colleg
hospit
mice
model
drug
treatment
mice
eighteen
mice
randomli
assign
three
group
n
sham
intestin
ir
dmso
ir
fenofibr
fenofibr
abcam
beij
china
suspend
dimethyl
sulphoxid
dmso
solut
final
concentr
mgml
fenofibr
mgkg
bodi
weight
equival
volum
dmso
vehicl
intraperiton
inject
mice
minut
ischemia
respect
intestin
ir
model
mice
anesthet
sodium
pentobarbit
mgkg
ip
allow
breath
spontan
surgeri
anesthet
abdomin
wall
open
midlin
incis
superior
mesenter
arteri
expos
clamp
aneurysm
clip
order
achiev
intestin
ischemia
state
pulseless
mesenteri
pale
small
bowel
appear
complet
minut
ischemia
clip
remov
reperfus
intestin
minut
return
puls
reestablish
pink
color
enhanc
intestin
peristalsi
assum
sign
reperfus
intestin
sham
group
underw
ident
oper
protocol
except
clamp
superior
mesenter
arteri
ischemiareperfus
time
set
accord
experi
pilot
studi
mice
perform
fluid
resuscit
intraperiton
inject
ml
normal
salin
surgeri
mice
sacrif
complet
intestin
ir
tissu
quickli
harvest
blood
sampl
collect
cardiac
punctur
centrifug
g
minut
order
collect
serum
tissu
serum
snap
frozen
liquid
nitrogen
store
analysi
addit
experi
observ
surviv
cours
hour
perform
n
surviv
experi
singl
dose
mgkg
fenofibr
equal
volum
dmso
vehicl
inject
intraperiton
one
hour
ischemia
histolog
examin
morpholog
chang
intestin
lung
examin
hematoxylin
eosin
stain
everi
lung
lobe
divid
equal
histopatholog
biochem
investig
briefli
portion
left
lung
upper
left
lobe
lower
left
lobe
right
lung
anterior
lobe
posterior
lobe
median
lobe
post
caval
lobe
separ
immers
buffer
formalin
phosphat
dehydr
alcohol
embed
paraffin
cut
section
middl
lobe
everi
section
includ
hilum
peripheri
extent
histolog
injuri
evalu
two
blind
experienc
investig
lung
injuri
evalu
level
absent
mild
moder
sever
injuri
score
observ
presenc
exud
hyperemiacongest
neutrophil
infiltr
intraalveolar
hemorrhagedebri
cellular
hyperplasia
ten
area
lung
tissu
section
lung
lobe
randomli
select
within
microscop
high
power
field
lung
injuri
score
assess
categori
everi
individu
mous
mean
score
section
lung
examin
total
lung
injuri
score
calcul
ad
score
categori
intestin
injuri
score
scale
describ
chiu
et
al
grade
mucos
villi
grade
edema
subepitheli
space
usual
apex
villu
often
capillari
congest
grade
subepitheli
space
moder
lift
epitheli
layer
lamina
propria
grade
epitheli
lift
side
villi
tip
may
denud
grade
villi
lamina
propria
dilat
capillari
expos
increas
cellular
lamina
propria
may
note
grade
disintegr
lamina
propria
presenc
hemorrhag
ulcer
intestin
injuri
grade
chiu
score
system
five
section
averag
repres
grade
anim
lung
tissu
lobe
individu
mice
remov
rins
pb
remov
excess
blood
organ
cut
mm
piec
homogen
use
tissu
homogen
two
freezethaw
cycl
perform
break
cell
membran
homogen
centrifug
minut
g
supernat
use
cytokin
determin
tissu
serum
level
cytokin
determin
enzymelink
immunosorb
assay
elisa
kit
specif
mous
b
abcam
beij
china
accord
manufactur
instruct
ino
alt
creatin
level
measur
use
commerci
assay
kit
abcam
beij
china
cytokin
level
measur
triplic
averag
western
blot
tissu
wash
pb
homogen
lysi
buffer
extract
g
tissu
fraction
bistri
gel
transfer
nitrocellulos
membran
block
bsa
trisbuff
salin
incub
rabbit
polyclon
cleav
abcam
beij
china
rabbit
polyclon
alanin
transaminas
abcam
beij
china
overnight
membran
incub
horseradish
peroxidaselabel
goat
antirabbit
igg
abcam
beij
china
band
detect
use
chemiluminesc
peroxidas
substrat
ecl
amersham
beij
china
expos
radiograph
film
kodak
beij
china
spss
program
spss
inc
chicago
il
usa
use
statist
analysi
data
express
mean
sd
percentag
distribut
analysi
conduct
shapirowilk
test
data
conform
normal
distribut
comparison
multipl
group
perform
scientif
report
doi
use
anova
lsd
compar
differ
individu
group
data
conform
normal
distribut
comparison
multipl
group
carri
kruskalw
test
differ
individu
group
compar
mannwhitney
u
test
surviv
rate
analyz
use
kaplanmei
logrank
test
statist
signific
set
p
valu
ir
led
sever
intestin
damag
character
extens
edema
inflamm
necrosi
vascular
congest
macroscop
appear
compar
sham
group
administr
fenofibr
one
hour
ischemia
attenu
sever
intestin
injuri
amelior
sign
ischem
dark
necrosi
although
intestin
still
appear
moder
edema
fig
histopatholog
examin
intestin
wall
denud
villi
accompani
sever
injuri
observ
gut
tissu
vehicl
group
compar
sham
group
fig
meanwhil
fenofibratetr
group
integr
intestin
structur
height
villi
extent
protect
ir
injuri
comparison
vehicl
group
fig
patholog
score
intestin
stain
indic
fenofibratetr
group
histolog
injuri
score
intestin
significantli
decreas
compar
vehicl
group
suggest
protect
effect
fenofibr
intestin
ir
injuri
fig
inflammatori
cytokin
includ
small
intestin
significantli
reduc
fenofibr
group
compar
vehicl
group
fig
term
apoptosi
indic
fenofibr
treat
mice
present
significantli
lesser
express
level
b
small
intestin
compar
vehicl
treat
mice
intestin
ir
moreov
express
small
intestin
mice
significantli
elev
fenofibr
group
comparison
vehicl
group
fig
caus
multipl
organ
injuri
system
inflammatori
respons
proinflammatori
cytokin
contributor
remot
organ
injuri
intestin
ir
hypothesi
base
assumpt
fenofibr
administr
decreas
express
level
inflammatori
cytokin
serum
therefor
reduc
distant
organ
injuri
evalu
secret
alt
serum
intestin
ir
consist
expect
serum
level
inflammatori
cytokin
significantli
decreas
compar
vehicl
group
tabl
system
inflammatori
indic
significantli
reduc
fenofibr
group
respect
compar
vehicl
group
blood
marker
remot
organ
injuri
alt
decreas
fenofibr
group
compar
vehicl
group
tabl
fenofibr
allevi
ali
intestin
ir
abat
distant
organ
injuri
liver
kidney
one
sever
damag
distant
organ
affect
intestin
ir
injuri
serv
lung
stain
indic
lung
tissu
vehicletr
mice
present
sever
histolog
chang
includ
intracellular
hemorrhag
alveolar
congest
exud
infiltr
inflammatori
cell
comparison
sham
group
fig
howev
administr
fenofibr
dramat
amelior
ali
histopatholog
alter
seen
significantli
reduc
lung
injuri
score
fig
tabl
apart
histolog
indic
also
measur
biochem
variabl
variabl
includ
ino
b
lung
tissu
ino
lung
tissu
significantli
abat
fenofibr
group
compar
vehicl
group
implic
protect
role
fenofibr
ali
intestin
ir
fig
b
besid
lung
tissu
express
b
significantli
suppress
fenofibr
treat
group
significantli
elev
fenofibr
group
comparison
vehicl
group
fig
order
evalu
apoptosi
lung
fenofibr
treatment
assess
express
lung
tissu
pulmonari
express
level
significantli
upregul
vehicl
group
intestin
ir
fenofibr
administr
significantli
decreas
express
level
compar
vehicl
group
fig
similarli
kidney
fenofibr
treatment
significantli
reduc
level
creatin
compar
vehicl
group
fig
liver
tissu
western
blot
indic
fenofibr
administr
significantli
downregul
express
alt
intestin
ir
compar
vehicl
group
fig
intestin
ir
injuri
superior
mesenter
arteri
block
one
hour
follow
one
hour
reperfus
serum
cytokin
alanin
aminotransferas
sham
fenofibratetr
vehicletr
group
measur
elisa
respect
data
express
mean
sd
n
p
vs
vehicl
p
vs
sham
administr
fenofibr
improv
surviv
rate
mice
suffer
intestin
ir
injuri
sinc
result
demonstr
protect
effect
fenofibr
therefor
perform
anoth
surviv
experi
mice
receiv
fenofibr
intraperiton
minut
ischemia
compar
control
mice
receiv
vehicl
observ
hour
compar
surviv
rate
use
kaplanmei
method
logrank
test
seven
mice
inject
fenofibr
dead
hour
postintestin
ir
three
mice
vehicl
group
still
aliv
hour
intestin
ir
gener
surviv
rate
fenofibr
group
significantli
higher
vehicl
group
fig
present
studi
demonstr
intestin
ir
neg
affect
lung
morpholog
induc
acut
lung
injuri
character
system
inflamm
apoptot
cell
death
lung
epithelium
mice
treat
fenofibr
show
amelior
inflammatori
respons
decreas
apoptot
indic
intestin
distant
organ
includ
lung
intestin
ir
moreov
fenofibr
improv
surviv
rate
model
intestin
ir
best
knowledg
first
studi
show
protect
effect
fenofibr
intestin
irinduc
ali
albeit
protect
effect
prove
allevi
injuri
organ
undergon
ir
rat
model
renal
ischemia
follow
hour
reperfus
administr
fenofibr
allevi
mda
content
mpo
activ
gener
proinflammatori
mediat
addit
express
nitric
oxid
marker
oxid
damag
reduc
treatment
fenofibr
renal
ir
model
cardiac
ir
model
fenofibr
effect
attenu
cardiac
injuri
reduct
infarct
size
oxid
stress
apriori
hypothesi
partli
base
antioxid
antiinflamm
properti
fenofibr
one
experi
fenofibr
intervent
rheumatoid
arthriti
patient
indic
three
month
long
administr
fenofibr
mgkg
allevi
inflammatori
mediat
c
reactiv
protein
circul
jia
z
et
al
found
fenofibr
decreas
level
downstream
protein
therefor
attenu
inflamm
cardiac
cell
result
consist
one
experi
result
small
intestin
significantli
downregul
fenofibr
treatment
ali
commonli
seen
clinic
syndrom
respiratori
failur
pathophysiolog
mechan
ali
induc
intestin
ir
remain
complic
wide
acknowledg
ali
result
integr
network
inflammatori
mediat
mani
inflammatori
cell
proinflammatori
mediat
exert
vital
role
onset
ali
regard
ali
etiolog
ir
suggest
occlus
supermesenter
arteri
caus
local
intestin
injuri
reperfus
process
activ
seri
system
inflammatori
respons
damag
multipl
organ
includ
lung
blood
circul
ali
alveolar
exud
bleed
neutrophil
accumul
lung
tissu
activ
often
use
assess
extent
inflamm
intestin
ir
ampl
evid
pivot
inflammatori
mediat
intestin
ircaus
ali
studi
found
administr
fenofibr
activ
significantli
decreas
intestin
lung
tissu
intestin
ir
injur
lung
epithelium
endothelium
also
contribut
develop
ali
one
featur
process
loss
cell
apoptosi
apoptosi
major
event
cell
death
occur
intestin
ir
mice
epithelium
endothelium
confirm
hypothesi
fenofibr
involv
regul
apoptosi
model
intestin
ir
activ
use
apoptot
index
evalu
degre
apoptosi
lung
tissu
experi
significantli
reduc
lung
tissu
fenofibr
treatment
therefor
could
extent
state
fenofibr
attenu
ircaus
ali
part
apoptosi
oxid
stress
anoth
facet
mechan
ir
injuri
confirm
effect
fenofibr
model
ir
injuri
appli
oxid
marker
close
relat
ir
physiolog
condit
inhibit
neutrophil
releas
platelet
accumul
ir
state
lung
tissu
dramat
increas
lead
mitochondria
inhibit
energi
metabol
dysfunct
reduc
concentr
lung
tissu
fenofibr
treat
group
consist
amelior
morpholog
present
lung
tissu
therefor
benefici
effect
fenofibr
ircaus
ali
partli
attribut
antioxid
properti
b
widelyacknowledg
transcript
factor
regul
distinct
inflammatori
cytokin
ir
normal
state
b
combin
inhibitor
within
cytoplasm
inact
form
stimul
patholog
condit
becom
phosphoryl
ubiquitin
b
releas
aggreg
nucleu
activ
relat
gene
transcript
demonstr
fenofibr
markedli
inhibit
activ
b
pathway
lung
intestin
mice
intestin
ir
injuri
activ
upregul
compar
vehicl
group
unveil
antiinflammatori
properti
fenofibr
intestin
ir
injuri
b
depend
pathway
sinc
b
activ
report
associ
alveolar
macrophag
activ
major
sourc
inflammatori
cytokin
b
pathway
macrophag
seem
reason
explan
mechan
antiinflamm
fenofibr
protect
ali
ir
limit
studi
first
place
amount
histolog
tissu
serum
mice
access
inflammatori
cytokin
oxid
protein
may
potenti
function
high
throughput
elisa
techniqu
measur
protein
less
tissu
may
best
solut
problem
futur
secondli
although
surviv
analysi
demonstr
pretreat
fenofibr
improv
surviv
rate
significantli
perform
lifesustain
oper
hour
routin
conduct
clinic
resuscit
clinic
intens
care
manag
perform
lifethreaten
state
therefor
whether
fenofibr
treatment
could
attenu
mortal
caus
intestin
ir
clinic
question
need
transit
research
support
confid
believ
fenofibr
serv
bridg
sever
intestin
ir
surgeri
third
place
util
assess
apoptosi
lung
tissu
whether
fenofibr
antiapoptot
effect
ali
need
investig
howev
report
trigger
apoptot
cascad
death
receptorcaspas
pathway
sinc
observ
fenofibr
decreas
product
sound
infer
fenofibr
allevi
apoptosi
ali
least
part
indirect
manner
conclus
studi
indic
fenofibr
significantli
attenu
intestin
ir
injuri
prevent
lung
ali
caus
intestin
ir
modul
inflammatori
respons
apoptosi
via
b
signal
pathway
basi
present
result
fenofibr
seem
promis
therapeut
agent
treatment
ali
caus
intestin
ir
